|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,496.30 INR | -0.26% |
|
-3.23% | -19.07% |
Business description: Bayer CropScience Limited
Number of employees: 1,169
Sales by Activity: Bayer CropScience Limited
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Agri Care | 42.61B | 47.34B | 51.4B | 51.03B | 54.73B |
Geographical breakdown of sales: Bayer CropScience Limited
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
India | 40.49B | 44.93B | 48.52B | 48.18B | 52.12B |
Germany | 986M | 1.07B | 1.48B | 1.8B | 927M |
Bangladesh | 881M | 920M | 873M | 551M | 913M |
Others | 253M | 427M | 520M | 493M | 775M |
Executive Committee: Bayer CropScience Limited
| Manager | Title | Age | Since |
|---|---|---|---|
Simon Wiebusch
CEO | Chief Executive Officer | - | 2023-10-31 |
Composition of the Board of Directors: Bayer CropScience Limited
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 2016-07-04 | |
Thomas Hoffmann
BRD | Director/Board Member | 54 | 2013-04-01 |
| Director/Board Member | 72 | 2019-09-30 | |
Simon Wiebusch
BRD | Director/Board Member | - | 2021-12-16 |
| Director/Board Member | 69 | 2024-07-22 | |
Sanjiv Rangrass
BRD | Director/Board Member | 64 | 2025-07-31 |
Company details: Bayer CropScience Limited
Other Agricultural Chemicals
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.26% | -3.23% | -26.29% | -2.93% | 2.25B | |
| -0.44% | -2.18% | +8.59% | +2.55% | 44.6B | |
| +0.11% | -.--% | -.--% | -.--% | 12.96B | |
| -0.17% | +0.38% | +116.91% | +135.90% | 10B | |
| +2.78% | +1.55% | +46.62% | +44.20% | 8.11B | |
| +0.35% | +0.02% | +35.88% | -5.46% | 7.12B | |
| 0.00% | -7.33% | +6.58% | -39.42% | 6.69B | |
| +1.04% | -3.35% | -17.55% | +477.96% | 6.09B | |
| -0.41% | -0.01% | -17.92% | -2.32% | 5.72B | |
| +0.85% | +0.06% | +27.74% | -3.39% | 4.05B | |
| Average | +0.38% | -1.08% | +18.06% | +60.71% | 10.76B | |
| Weighted average by Cap. | +0.11% | -1.08% | +19.28% | +40.95% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 506285 Stock
- Company Bayer CropScience Limited
Select your edition
All financial news and data tailored to specific country editions
